COPD clinical trials in Maryland
16 studies for COPD are looking for participants at sites in Maryland.
Cities in Maryland
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Oxon Hill
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Oct 2, 2026 · NCT06283966Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Johns Hopkins Bayview Medical Center- Site Number : 8400076, Baltimore
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Oct 1, 2026 · NCT07190222A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- Johns Hopkins Bayview Medical Center- Site Number : 8400009, Baltimore
RecruitingPhase 4
Ages 40 to 85 · All sexes · Updated Sep 22, 2026 · NCT07053423A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Baltimore
- Research Site, Baltimore
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 9, 2026 · NCT07082738Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- Johns Hopkins University, Baltimore
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 4, 2026 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Baltimore
- Research Site, Potomac
- Research Site, Rosedale
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Sep 3, 2026 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Baltimore
- Research Site, Columbia
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Sep 3, 2026 · NCT06883305STRIVE Post-Market Registry Study
- University of Maryland, Baltimore
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 3, 2026 · NCT04302272Multi-Center Clean Air Randomized Controlled Trial in COPD
- University of Maryland, Baltimore
- Johns Hopkins, Baltimore
- Tidal Health, Salisbury
RecruitingPhase 3
Ages 40 and older · All sexes · Updated Jul 31, 2026 · NCT06376994SPIROMICS Study of Early COPD Progression (SOURCE)
- Johns Hopkins Bayview Medical Center, Baltimore
RecruitingObservational studyHealthy volunteers welcome
Ages 30 to 55 · All sexes · Updated Jun 3, 2026 · NCT05033990Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Rockville
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Apr 9, 2026 · NCT06961214OMEGA - Dietary Intervention - COPD Trial
- Johns Hopkins Bayview Campus, Baltimore
Recruiting
Ages 40 and older · All sexes · Updated Mar 16, 2026 · NCT05297279Trial to Determine Effective Aspirin Dose in COPD
- Johns Hopkins Bayview Medical Center, Baltimore
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Mar 16, 2026 · NCT05265299Effectiveness of the WearME System for COPD Severity and Respiratory Function
- Johns Hopkins, Baltimore
- TidalHealth, Salisbury
RecruitingObservational study
Ages 21 to 100 · All sexes · Updated Sep 9, 2025 · NCT06751537Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Ascension St. Agnes Hospital, Baltimore
RecruitingObservational study
Ages 50 and older · All sexes · Updated Aug 5, 2025 · NCT06122077myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- University of Maryland - Baltimore, Baltimore
Recruiting
Ages 30 and older · All sexes · Updated Feb 6, 2025 · NCT05204888From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.